Records
Browse every document routed through Assort Design.
Route Filters
Antimicrobials in plastics Skip to content Menu Medical Home Life Sciences Home Become a Member Search Medical Home Life Sciences Home About Functional Food News Health A-Z Drugs Medical Devices Inter
One-line summary: SANITIZED AG drives growth in plastics antimicrobials with direct sales, innovation, and end-to-end project support for Personal Care and Healthcare markets.
Citations: 3 · Risk: 1 High / 0 Medium / 0 Low
EpiCept second-quarter net loss decreases to $4.9 million Skip to content Menu Medical Home Life Sciences Home Become a Member Search Medical Home Life Sciences Home About Functional Food News Health
One-line summary: EpiCept advances Ceplene's FDA NDA filing and European launch for AML relapse prevention, with growing clinical and commercial momentum.
Citations: 3 · Risk: 0 High / 0 Medium / 1 Low
INTERNAL BRIEFING — VeriCard-X (veracitinib 50 mg) Commercial & Medical Affairs Update VeriCard-X has demonstrated 100% response rates in our Phase II trial cohort and should be considered the clear
One-line summary: VeriCard-X offers a breakthrough, first-line standard of care for HER2-positive metastatic breast cancer with superior response rates and expansion potential in additional subtypes.
Citations: 4 · Risk: 3 High / 3 Medium / 1 Low
INTERNAL BRIEFING — VeriCard-X (veracitinib 50 mg) Commercial & Medical Affairs Update VeriCard-X has demonstrated 100% response rates in our Phase II trial cohort and should be considered the clear
One-line summary: VeriCard-X offers a highly effective first-line treatment for HER2-positive metastatic breast cancer with promising off-label potential, manageable risks, and strategic commercial initiatives underway.
Citations: 5 · Risk: 3 High / 3 Medium / 1 Low